Clinical efficacy of CT-guided iodine-125 seed brachytherapy in unresectable locoregionally recurrent breast cancer
CT-guided <sup>125</sup>I seed brachytherapy for locoregionally recurrent breast cancer is characterized by definite efficacy, minimal invasiveness, and fewer complications compared with external beam radiotherapy. It can serve as an important treatment option for locoregionally recurrent breast cancer, particularly in cases with poor control of localized progression-free survival, such as advanced disease, multisite recurrences, and triple-negative breast cancer, which is prone to distant metastasis.
Authors
- Liqiu Ji
- Guoxu Zhang (ORCID: https://orcid.org/0009-0005-1156-165X)
- Zhiguo Wang (ORCID: https://orcid.org/0000-0002-0811-2045)
- Wen‐Wen Zhang (ORCID: https://orcid.org/0000-0002-7620-5614)
- Shanhu Hao
Institutions
- Northern Hospital (AU)
- General Hospital of Shenyang Military Region (CN)
Publication Details
- Journal
- Journal of Contemporary Brachytherapy
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5114/jcb.2025.154105
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00